ESMO 2017: One in four small and early-stage breast cancers can be aggressive and benefit from adjuvant chemotherapy

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • One in four patients with T1abN0 breast tumours of less than 1 cm can benefit from adjuvant chemotherapy.

Why this matters

  • The study challenges the assumption that all patients with small breast tumours clinically classified as low-risk can avoid adjuvant chemotherapy after...